Mannin Research Revenue and Competitors
Estimated Revenue & Valuation
- Mannin Research's estimated annual revenue is currently $1M per year.
- Mannin Research's estimated revenue per employee is $77,500
Employee Data
- Mannin Research has 13 Employees.
- Mannin Research grew their employee count by -41% last year.
Mannin Research's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Financial Officer | Reveal Email/Phone |
2 | Senior Manager, CMC and Analytical Sciences | Reveal Email/Phone |
3 | Senior Manager, CMC & PD | Reveal Email/Phone |
4 | CMC Strategic Project Manager | Reveal Email/Phone |
5 | Executive Chairman | Reveal Email/Phone |
6 | Research And Development Scientist | Reveal Email/Phone |
Mannin Research Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.2M | 27 | 29% | $5M | N/A |
#2 | $1.7M | 11 | 22% | N/A | N/A |
#3 | $0.9M | 11 | -72% | $39.4M | N/A |
#4 | $1M | 13 | -84% | $23.8M | N/A |
#5 | $94.4M | 609 | 8% | N/A | N/A |
#6 | $3.4M | 22 | 10% | N/A | N/A |
#7 | $9.5M | 61 | -68% | N/A | N/A |
#8 | $18.1M | 117 | 30% | N/A | N/A |
#9 | $21.7M | 140 | -6% | N/A | N/A |
#10 | $1M | 13 | -41% | N/A | N/A |
What Is Mannin Research?
Mannin Research is a biotechnology company focused on the discovery, development, and commercialization of first-in-class therapeutics for vascular related diseases using the Tie2 mechanism of action. Mannin’s Tie2 platform technology addresses a number of vascular related diseases. Mannin is currently developing host-directed therapeutics to treat Acute Respiratory Distress Syndrome (ARDS) in COVID-19 patients.
keywords:N/AN/A
Total Funding
13
Number of Employees
$1M
Revenue (est)
-41%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $35M | 13 | 0% | N/A |
#2 | $7.5M | 13 | -19% | N/A |
#3 | $0.8M | 13 | -35% | N/A |
#4 | $1.1M | 13 | N/A | N/A |
#5 | $0.9M | 13 | N/A | N/A |